Published by:


depression generic receives tentative FDA approval

GUJARAT, India — Alembic Pharmaceuticals has received tentative approval from the Food and Drug Administration for its anti-depressive medication vilazodone hydrochloride, according to several published reports.Tentative approval is given when a generic drug is ready for approval before the patent exclusivity for the reference product has ended. Final approval is delayed until that time.

depression generic receives tentative FDA approval
QR Code
Embed the QR code on your website:
Download
Copy